Anti-tumor effects of the novel KIT mutant inhibitor M4205 in gastrointestinal stromal tumor (GIST) xenograft models

被引：0
|
作者：
De Sutter, L. [1 ]
Wozniak, A. [1 ]
Verreet, J. [1 ]
Vanleeuw, U. [1 ]
De Cock, L. [1 ]
Linde, N. [2 ]
Drechsler, C. [2 ]
Esdar, C. [2 ]
Sciot, R. [3 ]
Schoeffski, P. [4 ]
机构：
[1] Katholieke Univ Leuven, Lab Expt Oncol, Oncol, Leuven, Belgium
[2] Merck KGaA Germany, TIP Oncol, Darmstadt, Germany
[3] UZ Leuven, Univ Hosp Leuven, Pathol, Campus Gasthuisberg, Leuven, Belgium
[4] UZ Leuven, Univ Hosp Leuven, Med Oncol, Campus Gasthuisberg, Leuven, Belgium
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1514P
引用
收藏
页码：S1239 / S1239
页数：1
相关论文
共 50 条
  • [1] Anti-tumor effects of the novel KIT mutant inhibitor M4205 in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    De Sutter, Luna
    Wozniak, Agnieszka
    Verreet, Jasper
    Vanleeuw, Ulla
    De Cock, Lore
    Linde, Nina
    Drechsler, Christine
    Esdar, Christina
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [2] Antitumor Efficacy of the Novel KIT Inhibitor IDRX-42 (Formerly M4205) in Patient- and Cell Line-Derived Xenograft Models of Gastrointestinal Stromal Tumor (GIST)
    De Sutter, Luna
    Wozniak, Agnieszka
    Verreet, Jasper
    Vanleeuw, Ulla
    De Cock, Lore
    Linde, Nina
    Drechsler, Christine
    Esdar, Christina
    Sciot, Raf
    Schoffski, Patrick
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (15) : 2859 - 2868
  • [3] Anti-tumor effects of dovitinib in patient-derived gastrointestinal stromal tumor (GIST) xenograft models.
    Gebreyohannes, Yemarshet Kelemework
    Van Looy, Thomas
    Wozniak, Agnieszka
    Wellens, Jasmien
    Li, Haifu
    Cornillie, Jasmien
    Vanleeuw, Ulla
    Vreys, Lise
    Squires, Matthew
    Rodriguez, Ana-Maria
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Anti-tumor effects of dovitinib, a multi-target kinase inhibitor, in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    Gebreyohannes, Yemarshet Kelemework
    Van Looy, Thomas
    Wozniak, Agnieszka
    Wellens, Jasmien
    Li, Haifu
    Cornillie, Jasmien
    Vanleeuw, Ulla
    Vreys, Lise
    Squires, Matthew
    Rodringuez, Ana-Maria
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2015, 75
  • [5] A Novel Xenograft Model of Gastrointestinal Stromal Tumor (GIST)
    Sicklick, J. K.
    Leonard, S. Y.
    Mose, E.
    French, R. P.
    Criscuoli, M.
    Jaquish, D. V.
    Maruyama, K.
    Schwab, R.
    Cheresh, D. A.
    Lowy, A. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S20 - S20
  • [6] PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors
    Gebreyohannes, Yemarshet K.
    Burton, Elizabeth A.
    Wozniak, Agnieszka
    Matusow, Bernice
    Habets, Gaston
    Wellens, Jasmien
    Cornillie, Jasmien
    Lin, Jack
    Nespi, Marika
    Wu, Guoxian
    Zhang, Chao
    Bollag, Gideon
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (02) : 201 - 210
  • [7] PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors
    Yemarshet K. Gebreyohannes
    Elizabeth A. Burton
    Agnieszka Wozniak
    Bernice Matusow
    Gaston Habets
    Jasmien Wellens
    Jasmien Cornillie
    Jack Lin
    Marika Nespi
    Guoxian Wu
    Chao Zhang
    Gideon Bollag
    Maria Debiec-Rychter
    Raf Sciot
    Patrick Schöffski
    [J]. Clinical and Experimental Medicine, 2019, 19 : 201 - 210
  • [8] Robust activity of BLU-285, a potent and highly selective inhibitor of mutant KIT and PDGFRα, in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST)
    Gebreyohannes, Yemarshet K.
    Wozniak, Agnieszka
    Zhai, Madelina-Elena
    Wellens, Jasmien
    Cornillie, Jasmien
    Evans, Erica
    Gardino, Alexandra K.
    Lengauer, Christoph
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2017, 77
  • [9] E7080, an oral multitargeted tyrosine kinase inhibitor, has direct anti-tumor efficacy via inhibition of KIT signaling in gastrointestinal stromal tumor (GIST)
    Yamamoto, Yuji
    Watanabe, Tatsuo
    Tsuruoka, Akihiko
    Wakabayashi, Toshiaki
    Asada, Makoto
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [10] Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
    Hengning Ke
    Julhash U. Kazi
    Hui Zhao
    Jianmin Sun
    [J]. Cell & Bioscience, 6
12345